Fennec Pharmaceuticals (FRX) Stock Chart & Stock Price History C$13.75 +0.33 (+2.46%) As of 10/3/2025 03:56 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesBuy This Stock Fennec Pharmaceuticals Stock Price Performance The Fennec Pharmaceuticals (FRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 119.65%, with a year-to-date return of 55.02%. In the past month, the stock has increased 10.89%, reflecting recent market activity. As of the latest close, Fennec Pharmaceuticals traded at C$13.75 with a market cap of C$382.69 million and volume of 751 shares. Five years ago, the stock traded at C$9.33, representing a 47.37% increase over that period. At the time, it had a market cap of C$236.57 million and a volume of 3,852 shares. Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+5.85%1 Month Performance+10.89%3 Month Performance+15.64%Year-To-Date Performance+55.02%1 Year Performance+119.65%5 Year Performance+47.37% FRX Stock Chart for Monday, October, 6, 2025 FRX Chart by TradingView Fennec Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025C$13.42C$13.75+2.46%C$13.75C$13.65751 shsC$382.69 million10/02/2025C$12.99C$13.42+3.31%C$13.42C$13.42111 shsC$373.51 million10/01/2025C$12.99C$12.99C$12.99C$12.803,154 shsC$361.54 million09/30/2025C$12.59C$12.99+3.18%C$12.99C$12.803,154 shsC$361.54 million09/29/2025C$12.61C$12.59-0.16%C$12.77C$12.38849 shsC$350.41 million09/26/2025C$12.03C$12.61+4.82%C$12.61C$12.50752 shsC$350.96 million09/25/2025C$11.64C$12.03+3.35%C$12.03C$11.92203 shsC$334.82 million09/24/2025C$11.73C$11.64-0.77%C$11.88C$11.64623 shsC$323.96 million09/23/2025C$12.08C$11.73-2.90%C$12.04C$11.73813 shsC$326.47 million09/22/2025C$11.93C$12.08+1.26%C$12.08C$11.84653 shsC$336.21 million Get the Latest News and Ratings for FRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025C$12.06C$11.93-1.08%C$12.20C$11.441,370 shsC$332.04 million09/18/2025C$12.06C$12.06C$12.59C$12.06602 shsC$335.65 million09/17/2025C$12.35C$12.06-2.35%C$12.59C$12.06602 shsC$335.65 million09/16/2025C$12.03C$12.35+2.66%C$12.35C$11.96552 shsC$343.73 million09/15/2025C$12.78C$12.03-5.87%C$12.69C$11.852,334 shsC$334.82 million09/12/2025C$12.78C$12.78C$12.78C$12.78108 shsC$355.69 million09/11/2025C$12.71C$12.78+0.55%C$12.78C$12.78100 shsC$353.74 million09/10/2025C$12.19C$12.71+4.27%C$12.71C$12.71180 shsC$353.75 million09/09/2025C$12.19C$12.19C$12.40C$12.19905 shsC$339.27 million09/08/2025C$12.40C$12.19-1.69%C$12.40C$12.19905 shsC$339.27 million09/05/2025C$12.42C$12.40-0.16%C$12.75C$12.331,412 shsC$345.12 million Related Companies ITH Stock Chart AIM Stock Chart GPH Stock Chart CRDL Stock Chart CGC Stock Chart MDNA Stock Chart EQ Stock Chart CXF Stock Chart RGC Stock Chart BRM Stock Chart Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:FRX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
